ST Wanbang
SZSE · 002082
Market Cap$8.5B
Revenue$1.1B
P/E Ratio20.1
Listed OnSZSE
Ticker002082
IndustryDrug Manufacturers - Specialty & Generic
CEO / ExecMr. Shouming Zhao
HeadquartersTaizhou
MarketMainland China
Websitewww.wepon.com.cn
Overview
Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through two segments, the Pharmaceutical Business and the Medical Device Business. It offers drugs products used to treat cardiovascular and cerebrovascular diseases; and nervous, respiratory, mental, and digestive system diseases. The company also develo
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.